Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life.
The fastest growing segment of the U.S. population belongs to the aging segment, where the highest rates of breast cancer occur. The breast cancer market will remain a visibly important area of oncology. Companies are putting their research dollars into developing targeted breast cancer therapies that offer patients not only increased efficacy, but reduced side effects as well.
These innovative, targeted therapies have shown the greatest promise in the market and many are touting them as the future of breast cancer treatment. Combinations of these highly specific therapies with existing cytotoxic and hormonal therapies are rapidly becoming the standard of oncology care.
___________________________________
velashape fast computer software
Linear Mode
